Company Financials

Ascendis Pharma A/S Financials

United States dollar

business Ascendis Pharma A/S Company Profile

Main Stock Listing

NASDAQ: ASND

Market Capitalization $10.54 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 4, 2025

Trailing PE -26.67
Forward PE -44.10
Price to Sales TTM $28.58
Price to Book MRQ $-55.08
Enterprise to Revenue 29.16
Enterprise to EBITDA -32.69

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-03-31
Profit Margin -92.67%
Operating Margin -103.23%
Return on Assets TTM -22.39%
Return on Equity TTM 357.68%

Income Statement

Revenue TTM $433,500,191
Revenue per Share TTM $6.28
Quarterly Revenue Growth 5.30%
Gross Profit TTM $369,767,505
EBITDA $-386,618,354
Net Income to Common TTM $-401,724,390
Diluted EPS TTM $-6.86
Quarterly Earnings Growth YoY 5.28%

Balance Sheet

Total Cash MRQ $608,947,976
Total Cash per Share MRQ $8.58
Total Debt MRQ $
Total Debt to Equity MRQ -5.25
Current Ratio MRQ 1.04
Book Value per Share MRQ $-3.14

Cash Flow

Operating Cash Flow TTM $-257,404,596
Levered Free Cash Flow TTM $-156,886,643

ASND Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding 59,843,600
Float Shares 59,902,597
Avg 10 Volume 409,390
Avg 30 Volume None
Shares Short 2,693,234
Short Ratio 6.49
Short % of Shares 5.35%
% Held by Insiders 0.78%
% Held by Institutions 113.57%

Stock Price Summary

Beta 0.36
Fifty Two Week Low $111.09
Fifty Two Week High $183.00
Fifty Two Week Change 22.03%
Day 50 MA $167.18
Day 200 MA $146.11

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date